InsiderFlow

Christopher Richard Anzalone

ARWR

Christopher Richard Anzalone serves as Chief Executive Officer at Arrowhead Pharmaceuticals, Inc. (ARWR). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

20 trades

$57.40M

Net Position

Net Seller

$57.40M

Companies Traded

1

ARWR

Active Period

Oct 2021 – Jan 2026

20 total trades

Most Recent

Sell ARWR

Jan 2, 2026 · $871.7K

Christopher Richard Anzalone's Insider Trading at Arrowhead Pharmaceuticals, Inc. (ARWR)

Buys

0 · $0.00

Sells

20 · $57.40M

Total Shares Bought

0

Total Shares Sold

1,441,444

ARWR Price Chart
Loading chart...
DateTypeValue
Jan 2, 2026 Sell$871.7K
Dec 29, 2025 Sell$3.58M
Dec 19, 2025 Sell$1.77M
Dec 17, 2025 Sell$5.44M
Dec 12, 2025 Sell$12.35M
Apr 9, 2025 Sell$1.53M
Mar 13, 2025 Sell$775.0K
Mar 3, 2025 Sell$5.27M
Jan 2, 2025 Sell$219.5K
Dec 23, 2024 Sell$246.1K
Dec 18, 2024 Sell$567.5K
Jan 31, 2024 Sell$1.86M
Jan 2, 2024 Sell$308.6K
Dec 20, 2023 Sell$342.5K
Oct 25, 2023 Sell$589.2K
Sep 18, 2023 Sell$1.62M
May 3, 2023 Sell$4.13M
Feb 11, 2022 Sell$7.60M
Dec 15, 2021 Sell$4.05M
Oct 20, 2021 Sell$4.27M